Stay updated on Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial
Sign up to get notified when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.

Latest updates to the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page
- Check7 days agoChange DetectedAdded the alias 'Severe myoclonic epilepsy in infancy' to the Conditions section to reflect SMEI/Dravet terminology.SummaryDifference0.1%

- Check14 days agoChange DetectedRemoved 'Dravet syndrome' from the list of conditions on the Study Details page.SummaryDifference0.0%

- Check22 days agoChange DetectedThe site version updated from v3.4.3 to v3.5.0, with no visible changes to the Study Details page.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check36 days agoChange DetectedNo additions or deletions were observed; the page content appears unchanged.SummaryDifference0.1%

- Check43 days agoChange DetectedNo additions or deletions detected on the page; the content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cannabidiol in Dravet & Lennox-Gastaut Clinical Trial page.